GlassScriptPhysician profile
Anne Meccariello
NPI 1295735587
$575.04
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $255 · 2021: $49.00.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $188.43 | 2019-2020 | |
| Alcon Vision LLC | $69.50 | 2019-2021 | |
| Visioneering Technologies, INC. | $64.36 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $53.35 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $46.81 | 2019-2020 | |
| Coopervision INC. | $36.20 | 2019-2020 | |
| Abb Con-Cise Optical Group LLC | $32.39 | 2019-2020 | |
| Oasis Medical, INC. | $28.92 | 2019-2020 | |
| Allergan, INC. | $19.16 | 2021 | |
| Maculogix, INC. | $18.89 | 2019 | |
| Biotissue Holdings INC. | $17.03 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Meccariello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.